Alterations in Glucose Metabolism Induce Hypothermia Leading to Tau Hyperphosphorylation through Differential Inhibition of Kinase and Phosphatase Activities: Implications for Alzheimer's Disease
Open accessThe DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) brains contain neurofibrillary tangles (NFTs) composed of abnormally hyperphosphorylated tau protein. Regional reductions in cerebral glucose metabolism correlating to NFT densities have been reported in AD brains. Assuming that reduced glucose metabolism might cause abnormal tau hyperphosphorylation, we induced in vivo alterations of glucose metabolism in mice by starvation or intraperitoneal injections of either insulin or deoxyglucose. We found that the treatments led to abnormal tau hyperphosphorylation with patterns resembling those in early AD brains and also resulted in hypothermia. Surprisingly, tau hyperphosphorylation could be traced down to a differential effect of low temperatures on kinase and phosphatase activities. These data indicate that abnormal tau hyperphosphorylation is associated with altered glucose metabolism through hypothermia. Our results imply that serine-threonine protein phosphatase 2A plays a major role in regulating tau phosphorylation in the adult brain and provide in vivo evidence for its crucial role in abnormal tau hyperphosphorylation in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017
Diabetes mellitus and the risk of dementia: The Rotterdam Study
Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175
Alonso, A. D. C., Zaidi, T., Novak, M., Grundke-Iqbal, I., & Iqbal, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121119298 · Cited by 827
Bancher, C., Brunner, C., Lassmann, H., Budka, H., Jellinger, K., Wiche, G., Seitelberger, F., Grundke-Iqbal, I., Iqbal, K., & Wisniewski, H. M. (1989) · Brain Research · doi:10.1016/0006-8993(89)91396-6 · Cited by 818
Braak, F., Braak, H., & Mandelkow, E. M. (1994) · Acta Neuropathologica · doi:10.1007/bf00293315 · Cited by 772
Risk of Dementia among Persons with Diabetes Mellitus: A Population-based Cohort Study
Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'Brien, P. C., & Palumbo, P. J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009106 · Cited by 700
Monoclonal antibody AT8 recognises tau protein phosphorylated at both serine 202 and threonine 205
Goedert, M., Jakes, R., & Vanmechelen, E. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11484-e · Cited by 608
Matsuo, E. S., Shin, R.-W., Billingsley, M. L., Van deVoorde, A., O'Connor, M., Trojanowski, J. Q., & Lee, V. M. Y. (1994) · Neuron · doi:10.1016/0896-6273(94)90264-x · Cited by 576
Phosphoprotein Phosphatase Activities in Alzheimer Disease Brain
Gong, C., Singh, T. J., Grundke‐Iqbal, I., & Iqbal, K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb03603.x · Cited by 527
Insulin and Insulin-like Growth Factor-1 Regulate Tau Phosphorylation in Cultured Human Neurons
Hong, M., & Lee, V. M.-Y. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.31.19547 · Cited by 522
Phosphatase Activity Toward Abnormally Phosphorylated τ: Decrease in Alzheimer Disease Brain
Gong, C., Shaikh, S., Wang, J., Zaidi, T., Grundke‐Iqbal, I., & Iqbal, K. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65020732.x · Cited by 438
Gong, C.-X., Lidsky, T., Wegiel, J., Zuck, L., Grundke-Iqbal, I., & Iqbal, K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.8.5535 · Cited by 405
The Role of Mitogen-Activated Protein Kinase Pathways in Alzheimer’s Disease
Zhu, X., Lee, H.-G., Raina, A. K., Perry, G., & Smith, M. A. (2002) · Neurosignals · doi:10.1159/000067426 · Cited by 391
Sontag, E., Nunbhakdi-Craig, V., Lee, G., Bloom, G. S., & Mumby, M. C. (1996) · Neuron · doi:10.1016/s0896-6273(00)80250-0 · Cited by 391
Distribution, Levels, and Activity of Glycogen Synthase Kinase-3 in the Alzheimer Disease Brain
PEI, J.-J., TANAKA, T., TUNG, Y.-C., BRAAK, E., IQBAL, K., & GRUNDKE-IQBAL, I. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199701000-00007 · Cited by 371
Arendt, T., Stieler, J., Strijkstra, A. M., Hut, R. A., Rüdiger, J., Van der Zee, E. A., Harkany, T., Holzer, M., & Härtig, W. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-18-06972.2003 · Cited by 357
Zheng‐Fischhöfer, Q., Biernat, J., Mandelkow, E., Illenberger, S., Godemann, R., & Mandelkow, E. (1998) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1998.2520542.x · Cited by 321
PP2A mRNA Expression Is Quantitatively Decreased in Alzheimer's Disease Hippocampus
Vogelsberg-Ragaglia, V., Schuck, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2001) · Experimental Neurology · doi:10.1006/exnr.2001.7630 · Cited by 281
Oxford textbook of geriatric medicine
Evans, J. (2000) · Oxford University Press eBooks · Cited by 281
Goedert, M., Cohen, E. S., Jakes, R., & Cohen, P. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)81418-l · Cited by 272
Functional Neurobiology of Aging
(2001) · Elsevier eBooks · doi:10.1016/b978-0-12-351830-9.x5000-8 · Cited by 248
Lesort, M., Jope, R. S., & Johnson, G. V. W. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0720576.x · Cited by 240
Sutherland, C., & Cohen, P. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)80112-6 · Cited by 238
Kins, S., Crameri, A., Evans, D. R. H., Hemmings, B. A., Nitsch, R. M., & Götz, J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102621200 · Cited by 203
Szendrei, G. I., Lee, V. M. ‐., & Otvos, L. (1993) · Journal of Neuroscience Research · doi:10.1002/jnr.490340212 · Cited by 200
Planel, E., Yasutake, K., Fujita, S. C., & Ishiguro, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m102780200 · Cited by 197
Self-citationFox, R. H., Woodward, P. M., Exton-Smith, A. N., Green, M. F., Donnison, D. V., & Wicks, M. H. (1973) · BMJ · doi:10.1136/bmj.1.5847.200 · Cited by 196
Bennecib, M., Gong, C.-X., Grundke-Iqbal, I., & Iqbal, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)02203-1 · Cited by 184
Wang, J., Grundke, I., & Iqbal, K. (1996) · Molecular Brain Research · doi:10.1016/0169-328x(95)00316-k · Cited by 175
ENZYMIC AND CEREBRAL METABOLIC EFFECTS OF 2‐DEOXY‐d‐GLUCOSE
Horton, R. W., Meldrum, B. S., & Bachelard, H. S. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb05996.x · Cited by 165
Hypoglycaemia: brain neurochemistry and neuropathology
Auer, R. N., & Siesjö, B. K. (1993) · Baillière's Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80210-1 · Cited by 164
Hasegawa, M., Jakes, R., Crowther, R. A., Lee, V. M.-Y., Ihara, Y., & Goedert, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00271-2 · Cited by 156
Role of Serine/Threonine Protein Phosphatase in Alzheimer’s Disease
Tian, Q., & Wang, J. (2002) · Neurosignals · doi:10.1159/000067425 · Cited by 156
Truncation of CDK5 Activator p35 Induces Intensive Phosphorylation of Ser202/Thr205 of Human Tau
Hashiguchi, M., Saito, T., Hisanaga, S.-I., & Hashiguchi, T. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207426200 · Cited by 149
Maccioni, R. B., Otth, C., Concha, I. I., & Muñoz, J. P. (2001) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2001.02024.x · Cited by 147
Cheng, B., & Mattson, M. P. (1992) · Experimental Neurology · doi:10.1016/0014-4886(92)90120-f · Cited by 142
Calpain‐mediated degradation of p35 to p25 in postmortem human and rat brains
Taniguchi, S., Fujita, Y., Hayashi, S., Kakita, A., Takahashi, H., Murayama, S., Saido, T. C., Hisanaga, S., Iwatsubo, T., & Hasegawa, M. (2001) · FEBS Letters · doi:10.1016/s0014-5793(00)02431-5 · Cited by 141
Sato, S., Tatebayashi, Y., Akagi, T., Chui, D.-H., Murayama, M., Miyasaka, T., Planel, E., Tanemura, K., Sun, X., Hashikawa, T., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202241200 · Cited by 132
Self-citationHuitrón‐Reséndiz, S., Sánchez-Alavez, M., Gallegos, R. A., Berg, G. I., Crawford, E. F., Giacchino, J. L., Games, D., Henriksen, S. J., & Criado, J. R. (2002) · Brain Research · doi:10.1016/s0006-8993(01)03373-x · Cited by 130
Paired helical filament tau in Alzheimer's disease. The kinase connection.
Trojanowski, J. Q., & Lee, V. M. ‐. (1994) · PubMed · Cited by 124
The Cerebellum in Alzheimer's Disease
Larner, A. J. (1997) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000106632 · Cited by 124
Starvation induces tau hyperphosphorylation in mouse brain: implications for Alzheimer's disease
Yanagisawa, M., Planel, E., Ishiguro, K., & Fujita, S. C. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01480-5 · Cited by 123
Self-citationOhshima, T., Ogawa, M., Veeranna, Hirasawa, M., Longenecker, G., Ishiguro, K., Pant, H. C., Brady, R. O., Kulkarni, A. B., & Mikoshiba, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.051628498 · Cited by 122
Self-citationHypothermia in mice tested in Morris water maze
Iivonen, H., Nurminen, L., Harri, M. N. E., Tanila, H., & Puoliväli, J. T. (2003) · Behavioural Brain Research · doi:10.1016/s0166-4328(02)00369-8 · Cited by 120
Regional cerebral glucose metabolism and postmortem pathology in Alzheimer’s disease
Mielke, R., Schröder, R., Fink, G. R., Kessler, J., Herholz, K., & Heiß, W.-D. (1996) · Acta Neuropathologica · doi:10.1007/s004010050410 · Cited by 111
Su, J. H., Cummings, B. J., & Cotman, C. W. (1994) · NeuroReport · doi:10.1097/00001756-199411000-00037 · Cited by 110
1Carbohydrate metabolism in vivo: Regulation of the blood glucose level
Newsholme, E. A. (1976) · Clinics in Endocrinology and Metabolism · doi:10.1016/s0300-595x(76)80040-0 · Cited by 105
Tissue‐specific expression of mRNAs encoding α‐ and β‐catalytic subunits of protein phosphatase 2A
Khew-Goodall, Y., & Hemmings, B. A. (1988) · FEBS Letters · doi:10.1016/0014-5793(88)80493-9 · Cited by 102
Bussière, T., Hof, P. R., Vanbesien-Mailliot, C., Brown, C., Caillet‐Boudin, M., Perl, D. P., Buée, L., & Delacourte, A. (1999) · Acta Neuropathologica · doi:10.1007/s004010050978 · Cited by 102
Stress‐induced hyperphosphorylation of tau in the mouse brain
Okawa, Y., Ishiguro, K., & Fujita, S. C. (2003) · FEBS Letters · doi:10.1016/s0014-5793(02)03883-8 · Cited by 98
Self-citationIdentification and distribution of axonal dystrophic neurites in Alzheimer's disease
Su, J. H., Cummings, B. J., & Cotman, C. W. (1993) · Brain Research · doi:10.1016/0006-8993(93)91063-x · Cited by 95
Phosphorylation of Tau, Aβ-Formation, and Apoptosis After In Vivo Inhibition of PP-1 and PP-2A
Arendt, T., Holzer, M., Fruth, R., Brückner, M. K., & Gärtner, U. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00003-7 · Cited by 93
Analysis of phosphorylation of tau with antibodies specific for phosphorylation sites
Ishiguro, K., Sato, K., Takamatsu, M., Park, J., Uchida, T., & Imahori, K. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12206-0 · Cited by 90
Self-citationRole of GSK‐3β in Alzheimer's disease pathology
Planel, E., Sun, X., & Takashima, A. (2002) · Drug Development Research · doi:10.1002/ddr.10100 · Cited by 85
Self-citationCerebellar glucose consumption in normal and pathologic states using fluorine-FDG and PET.
Kushner, M., Tobin, M., Alavi, A., Chawluk, J. B., Rosen, M., Fazekas, F., Alavi, J. Β., & Reivich, M. (1987) · PubMed · Cited by 76
Rapid reversible phosphorylation of rat brain tau proteins in response to cold water stress
Korneyev, A., Binder, L. I., & Bernardis, J. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11546-3 · Cited by 57
Schmidt, K., Kins, S., Schild, A., Nitsch, R. M., Hemmings, B. A., & Götz, J. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02274.x · Cited by 54
Stein, D. J., Buchsbaum, M. S., Hof, P. R., Siegel, B. V., Jr., & Shihabuddin, L. (1997) · Neuropsychobiology · doi:10.1159/000026471 · Cited by 46
Okadaic Acid-Stimulated Degradation of p35, an Activator of CDK5, by Proteasome in Cultured Neurons
Saito, T., Ishiguro, K., Onuki, R., Nagai, Y., Kishimoto, T., & Hisanaga, S. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9739 · Cited by 43
Self-citationIn vivo glucose utilization in rat tissues during the three phases of starvation
Cherel, Y., Burnol, A., Leturque, A., & Maho, Y. L. (1988) · Metabolism · doi:10.1016/0026-0495(88)90063-7 · Cited by 41
Neurochemical imaging of Alzheimer's disease and other degenerative dementias.
Frey, K. A., Minoshima, S., & Kuhl, D. E. (1998) · PubMed · Cited by 41
Diminished neuronal metabolic activity in Alzheimer's disease
Salehi, A., & Swaab, D. F. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050216 · Cited by 38
Diabetes mellitus and thermoregulation
Scott, A. R., Bennett, T. M., & Macdonald, I. A. (1987) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y87-215 · Cited by 37
Gong, C., Lidsky, T. I., Węgiel, J., Grundke, I., & Iqbal, K. (2001) · Brain Research Protocols · doi:10.1016/s1385-299x(00)00046-5 · Cited by 35
Body temperature as a risk factor for Alzheimer’s disease
Holtzman, A. H., & Simon, E. W. (2000) · Medical Hypotheses · doi:10.1054/mehy.2000.1085 · Cited by 27
Screening for hypothermia in the ambulatory elderly. The Maine experience
Keilson, L. (1985) · JAMA · doi:10.1001/jama.254.13.1781 · Cited by 27
Horwitz, B. A., Gabaldón, A. M., & McDonald, R. B. (2001) · Elsevier eBooks · doi:10.1016/b978-012351830-9/50061-5 · Cited by 9
Cited by
Tau in physiology and pathology
Wang, Y., & Mandelkow, E. (2016) · Nature Reviews Neuroscience · doi:10.1038/nrn.2015.1 · Cited by 2,251
Reducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892
Tau pathology and neurodegeneration
Spillantini, M. G., & Goedert, M. (2013) · The Lancet Neurology · doi:10.1016/s1474-4422(13)70090-5 · Cited by 1,133
Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics
Jope, R. S., Yuskaitis, C. J., & Beurel, E. (2007) · Neurochemical Research · doi:10.1007/s11064-006-9128-5 · Cited by 774
“Thus, injection of insulin increased GSK3 phosphorylation in mouse brain [131] and brain GSK3 phosphorylation was reduced by blockade of insulin signaling by knockout of the insulin receptor [132] and in mice with diet-induced insulinresistance [133].”
BackgroundGong, C.-X., & Iqbal, K. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785909111 · Cited by 644
Metadata
- Authors
- Planel, E., Miyasaka, T., Launey, T., Chui, D.-H., Tanemura, K., Sato, S., Murayama, O., Ishiguro, K., Tatebayashi, Y., & Takashima, A.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2004-03-10
- Volume
- 24
- Issue
- 10
- Pages
- 2401-2411
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2126279450
- Cited by
- 261
- References
- 67
- FWCI
- 9.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.